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The bitterness of racemic praziquantel (Rac-PZQ) constrains its use as an in-feed treatment 24 
against monogenean flukes in finfish aquaculture. Evidence exists in mammals that the R-(−) 25 
enantiomer of PZQ is less bitter than the S-(+) enantiomer. If fish exhibit this same response 26 
then the recently described techniques for the large-scale resolution of R-(−)-PZQ from Rac-27 
PZQ could facilitate the wide-spread application of this effective anthelmintic compound via 28 
feed. 29 
The hypothesis that yellowtail kingfish Seriola lalandi would find R-(−)-PZQ more palatable 30 
than Rac-PZQ and S-(+)-PZQ was tested in four trials. During the first three trials, the 31 
palatability of diets top-coated with 10 g kg-1 of Rac-PZQ or its two enantioseparated isomers 32 
were compared in small (85 to 160 g) and large (1.2 kg) yellowtail kingfish. A fourth trial 33 
compared the palatability of R-(−)-PZQ and Rac-PZQ at dietary inclusion levels of 2.5, 5.0 34 
and 10.0 g kg-1 in small yellowtail kingfish (170 grams). 35 
Ingestion data showed R-(−)-PZQ to be no more palatable than either Rac-PZQ or S-(+)-PZQ 36 
to yellowtail kingfish, regardless of size. Indeed, evidence suggested the S-(+)-PZQ to be 37 
slightly more palatable than both R-(−)-PZQ and Rac-PZQ. From these data we hypothesise 38 
that the strong smell of R-(−)-PZQ (which was not present in S-(+)-PZQ) is an equally 39 
important determinant to palatability as taste in yellowtail kingfish. Results demonstrate that 40 
dietary inclusion level is a more important determinant to palatability than PZQ chirality, 41 
however administration of R-(−)-PZQ may still be advantageous if it is demonstrated to be 42 
the only enantiomer efficacious against monogeneans. 43 
  44 
 
 
1. Introduction 45 
 46 
Praziquantel (PZQ) is a broad spectrum anthelmintic compound that has been used in the 47 
treatment of trematode and cestode infections in human and veterinary medicine for over 40 48 
years (Andrews, Thomas, Pohlke & Seubert 1983;  Day, Bennett & Pax 1992). In 49 
aquaculture, PZQ has been demonstrated to be highly effective against a range of internal and 50 
external parasites in a wide range of fish species; mainly in the form of bath treatments at 51 
concentrations ranging from 2.5 to 1000 mg L-1 for periods of between 4 minutes and 48 52 
hours (Sharp, Diggles, Poortenaar & Willis 2004;  Tubbs & Tingle 2006). This method of 53 
administration, however, is expensive for sea cage operations and results in the discharge of 54 
large quantities of PZQ into the environment. 55 
The oral application of PZQ in aquaculture has many advantages over bath treatments 56 
however its strong bitter taste is a major constraint to this delivery method (Hirazawa, 57 
Mitsuboshi, Hirata & Shirasu 2004;  Williams, Ernst, Chambers & Whittington 2007). 58 
Traditional methods of taste masking, such as the addition of aromas or sugar, are ineffective 59 
in improving the taste of praziquantel (Watson 2009). Partridge, Michael & Thuillier (2014) 60 
demonstrated that microencapsulation of PZQ was effective in improving the palatability of 61 
PZQ in fish, however the microcapsules tested appeared to reduce bioavailability and 62 
palatability issues still remained at the high dietary inclusion levels required to achieve 63 
effective doses in large fish.   64 
PZQ is synthesized as a racemate (Rac-PZQ); an equal combination of the R-(−) and S-(+) 65 
enantiomers (Woelfle, Seerden, de Gooijer, Pouwer, Olliaro & Todd 2011). Meyer, Sekljic, 66 
Fuchs, Bothe, Schollmeyer & Miculka (2009) found that the S-(+)-PZQ enantiomer is the 67 
main contributor to the bitter taste of the drug in humans and Oppel (2008) demonstrated 68 
 
 
improved taste response in cats to R-(−)-PZQ during acceptance tests with medicated oral 69 
pastes. Furthermore, it has been demonstrated that the R-(−)-PZQ is the only enantiomer 70 
effective against the trematode Schistosoma mansoni (Staudt, Schmahl, Blaschke & 71 
Mehlhorn 1992). Despite the negative attributes of S-(+)-PZQ, PZQ has always been 72 
administered in the racemic form, as methods to directly synthesise pure R-(−)-PZQ or to 73 
resolve (enantioseparate) Rac-PZQ into its enantiomers on a commercial scale have not 74 
existed. Recently, however, two different techniques have been described for the large-scale 75 
resolution of Rac-PZQ into its enantiomers (Woelfle et al. 2011), potentially paving the way 76 
for the wide-scale administration of only R-(−)-PZQ. 77 
Studies have not been conducted on whether fish find R-(−)-PZQ less bitter than S-(+)-PZQ 78 
or if the former is more efficacious than the latter against monogenean flukes. If fish show 79 
the same positive response to the taste of R-(−)-PZQ as mammals and if R-(−)-PZQ is the 80 
only enantiomer effective against monogenean flukes, then the constraints to the oral delivery 81 
of PZQ to fish infected with monogeneans will be overcome and the current administrative 82 
doses of Rac-PZQ could be reduced. Such advancements would see PZQ becoming the drug 83 
of choice against monogeneans.  84 
The genus Seriola forms the largest true marine finfish aquaculture industry in the world, 85 
with over 150,000 tonnes per annum produced in Japan from three different species (Seriola 86 
quinqueradiata (Temminck & Schlegel), Seriola dumerili (Risso) and Seriola lalandi 87 
(Valenciennes)) (Nakada 2008). New Seriola industries are also developing in many other 88 
regions of the world including Australia and New Zealand, the Americas and Europe (Benetti 89 
2008;  Blanco Garcia, Partridge, Flik, Roques & Abbink 2014;  Booth, Allan & Pirozzi 2010;  90 
Mylonas, Papandroulakis, Smboukis, Papadaki & Divanach 2004;  Poortenaar, Hooker & 91 
Sharp 2001). All species of Seriola are susceptible to a range of monogenean parasites which 92 
affect the economic viability of their production (Hutson, Ernst & Whittington 2007). The 93 
 
 
typical treatment for such parasites is the routine bathing of fish in hydrogen peroxide, a 94 
process which is labour intensive, logistically challenging and potentially dangerous to both 95 
the fish and operators if not properly executed. Furthermore, this management practice is 96 
expensive, with estimates that it contributes up to 20% of the cost of production (Ernst, 97 
Whittington, Corneillie & Talbot 2005). Praziquantel has been demonstrated to be effective 98 
against monogeneans infesting yellowtail kingfish Seriola lalandi (Valenciennes) (see Sharp 99 
et al. 2004, Tubbs & Tingle 2006), as too has the constraint of its bitterness to in-feed 100 
application (Partridge et al. 2014;  Williams et al. 2007). The current study tested the 101 
hypothesis that enantioseparated R-(−) PZQ will be more palatable than Rac-PZQ, which will 102 
in turn be more palatable than S-(+)-PZQ to yellowtail kingfish. 103 
 104 
2. Methods 105 
2.1. Praziquantel 106 
 107 
Racemic praziquantel (TNN Development Company, China) was obtained under an import 108 
consent permit issued by the Australian Pesticides and Veterinary Medicines Authority 109 
(APVMA) (Permit number KP40F37). It was separated into its two enantiomers based on 110 
methods described by Woelfle et al. (2011). The purity and enantiomeric ratios of all PZQ 111 
samples were independently assessed by the University of Sydney against certified standards. 112 
Purity was assessed using 1H NMR Analysis (Bruker AVANCE 200 spectrometer, 1H at 113 
200.13 MHz and 300 K) following dissolution of 20 mg of sample into 0.5 mL of CDCl3. 114 
The enantiomeric ratios of each sample were quantified using enantioselective normal phase 115 
HPLC analysis on a Waters 510 HPLC pump with a PDA detector. A Daicel Chiralcel OD-H 116 
analytical column (5 μm, 4.6 × 250 mm) was used with isopropanol/hexane/ TEA = 60:40:0.1 117 
 
 
as the mobile phase at a flow rate of 0.5 mL min-1 and with retention times of R-(−)-PZQ and 118 
S-(+)-PZQ of 14 and 16 minutes, respectively 119 
2.2. Experimental Design 120 
 121 
Four palatability trials outlined in Table 1 were conducted at the Australian Centre for 122 
Applied Aquaculture Research (ACAAR) in Fremantle, Western Australia. The first three 123 
trials measured the ingestion of diets containing 10 g PZQ kg-1 by small (85 -160 g) and large 124 
(1.2 kg) fish. Whilst this inclusion level is much higher than required to deliver effective 125 
doses (50 – 150 mg PZQ kg body weight (BW) -1) in the small fish, it was chosen on the basis 126 
that it will deliver effective doses across a wide range of fish sizes and therefore represents a 127 
useful model. An additional trial investigated the effect of varying dietary inclusion levels of 128 
R-(−) PZQ and Rac-PZQ on ingestion by small yellowtail kingfish. 129 
In each trial, five yellowtail kingfish were stocked into replicate 180 L (Trials 1, 2 & 4) or 130 
1,500 L (Trial 3) tanks with the number of replicates indicated in Table 1. Each trial used 131 
new fish with no previous exposure to PZQ. Each tank was supplied with flowing seawater 132 
(33 g L-1) at exchange rates of 300% and 100% hr-1 in the small and large tanks, respectively. 133 
These exchange rates generated a tangential current which rapidly moved any uneaten food to 134 
a central pipe, where it was extracted into a collection cup on the outside of the tank. Each 135 
tank also had a single, central air stone to oxygenate the water and assist with the movement 136 
of waste across the tank floor towards the central pipe.  All trials were conducted under a 137 
natural photoperiod and in water temperatures detailed in Table 1.  138 
Each palatability trial ran for 5 days and was preceded by a period of 5 days acclimation to 139 
the experimental tanks, during which time the fish were fed the control diet described below. 140 
Prior to stocking, fish were anaesthetised (isoeugenol 20 mg L-1 (AQUI-S, Lower Hutt, New 141 
 
 
Zealand)) and weighed to the nearest 1 g on a digital balance. During each trial, fish were fed 142 
daily at 0900 and 1500 on Nova ME (Skretting Australia™) pellets of 3mm (for small fish) 143 
or 9 mm (for large fish), top-coated with gelatine and the appropriate PZQ treatment, or the 144 
same diet coated only with gelatine (control). Each treatment diet was prepared in a 500 g 145 
batch by thoroughly hand-mixing the required amount and type of PZQ powder. Pellets were 146 
then top-coated with a 20% (w/v) gelatine solution at the rate of 50 mL kg-1 to adhere the 147 
PZQ to the surface (Partridge et al. 2014). Following the addition of gelatine the pellets were 148 
hand-mixed for a further 5 minutes to ensure a homogeneous coverage of gelatine and PZQ. 149 
Pellets were then spread in a thin layer and placed in a cool-room at 8°C to allow the gelatine 150 
to set. All pellets were prepared 1-2 days prior to the commencement of each trial and were 151 
stored in the cool-room prior to feeding.  152 
During each trial, fish were offered a fixed ration based on their mean weight and water 153 
temperature using Seriola feed tables (Masumoto 2002). At each feeding period the fixed 154 
ration was offered slowly, allowing adequate time for the fish to encounter each pellet. Once 155 
encounters ceased, no further food was added to the tank. Five minutes after feeding ceased, 156 
rejected pellets were counted in the collection cup and converted to a weight of pellets based 157 
on their average dry weight. The weight of pellets eaten each day was summed from the 158 
morning and afternoon feeds and expressed as a percentage of the total ration offered 159 
according to the formula below, where ‘offered’ is the total weight of food in the daily ration, 160 
‘rejected’ is the weight of pellets recovered in the collection cup and ‘not offered’ is the 161 
weight of pellets not fed into the tank. 162 
% 𝑜𝑓 𝑑𝑖𝑒𝑡 𝑒𝑎𝑡𝑒𝑛 =
𝑜𝑓𝑓𝑒𝑟𝑒𝑑 (𝑔) − (𝑟𝑒𝑗𝑒𝑐𝑡𝑒𝑑 (𝑔) +  𝑛𝑜𝑡 𝑜𝑓𝑓𝑒𝑟𝑒𝑑 (𝑔))
𝑜𝑓𝑓𝑒𝑟𝑒𝑑 (𝑔)
 × 100 
 These percentage data were arcsine transformed and compared between treatments by 163 
repeated measures analysis of variance, followed by post hoc Tukey’s HSD tests on least 164 
 
 
square means. Average daily ingestion data from Trial 4 were arcsine transformed then 165 
analysed by a two-way analysis of variance (with factors of dietary inclusion level and PZQ 166 
type), followed by Tukey’s HSD tests. Statistical tests were performed on JMP (version 7, 167 
SAS, Cary, NC) and significance was accepted at p < 0.05.  168 
3. Results 169 
All batches of PZQ used in the trials had virtually identical 1H NMR spectra to the pure 170 
commercial standard, demonstrating a very high purity. The R-(−)-PZQ used in Trial 1 was 171 
97.8% R-(−)-PZQ, which was increased by further resolution to 99.6% in the batch used in 172 
all subsequent trials. The S-(+)-PZQ used in all trials contained 88.2% S-(+)-PZQ and 11.2% 173 
R-(−)-PZQ. It was observed that the characteristic smell of Rac-PZQ was more concentrated 174 
and acrid in the R-(−)-PZQ than in the Rac-PZQ, whilst the S-(+)-PZQ had very little smell.  175 
3.1. Trial 1 176 
Those fish fed the control diet ate 100% of their ration and were excluded from the data 177 
analysis. The percentage of medicated diets eaten on each day is shown in Figure 1. Repeated 178 
measures analysis of variance revealed no effect of time (P = 0.21), PZQ treatment (P = 0.56) 179 
or their interaction (P = 0.08) on the ingestion of medicated diets. The pooled average 180 
ingestion across time and medicated treatments was 32 ± 2%. While there was some 181 
indication that fish offered the diet medicated with S-(+)-PZQ ate more of their ration (54 ± 182 
22%) than the other medicated treatments (23 ± 6%) on day 1, this difference was not 183 
significant.  184 
3.2. Trial 2 185 
Fish in the control treatment consumed 100% of their ration and were excluded from the data 186 
analysis. The percentage of diet eaten in each treatment on each day is shown in Figure 2. 187 
 
 
Repeated measures analysis of variance revealed no significant effect of medicated treatment 188 
on ingestion rate (P = 0.15), but a significant effect of time (P < 0.0001), with no interaction 189 
between these factors (P = 0.12). Post hoc tests found no difference in ingestion between days 190 
1 and 4, however all fish offered medicated diets ate significantly less food on day 5 (14.4 ± 191 
5.0%) compared to previous days. The pooled average intake for all medicated diets across 192 
the 5 day feeding period was 38 ± 3%. There was no difference in ingestion between the R-193 
(−)-PZQ with a purity of 97.8% (ingestion rate 32.3 ± 4.0%) and the more refined R-(−)-PZQ 194 
with a purity of 99.6% (ingestion rate 39.2 ± 4.0%). As in Trial 1, those fish offered the diet 195 
medicated with S-(+)-PZQ ate more food on day 1 (57.4 ± 7.4%) than the other medicated 196 
diets (35.6 ± 3.1%), but this difference was not significant.  197 
3.3. Trial 3 198 
The percentage of diet eaten by the large fish on each day is shown in Figure 3. While there 199 
was no control treatment included in this trial (due to a constraint on the number of tanks 200 
available) all fish ate 100% of their ration during the five day acclimation period and in the 201 
days immediately following the termination of the trial. Consumption of all medicated diets 202 
by the large fish in this trial was lower than seen in the previous two trials with small fish. 203 
Repeated measures analysis of variance revealed a significant effect of treatment (P = 0.006), 204 
time (P = 0.001) and their interaction (P = 0.01) on ingestion. Post hoc tests showed that 205 
those fish offered the diet medicated with S-(+)-PZQ ate significantly more (17.4 ± 1.3%) 206 
than those offered diets medicated with R-(−)-PZQ (2.5 ± 1.3%) and Rac-PZQ (2.3 ± 1.3%), 207 
which did not differ from each other. The difference between S-(+)-PZQ and the other two 208 
treatments was most pronounced on Day 1 when those fish offered S-(+)-PZQ ate 41.9% of 209 
their ration.  210 
 
 
3.4. Trial 4 211 
Fish in the control treatment consumed 100% of their ration and were excluded from the data 212 
analysis. Average daily ingestion of each medicated diet is shown in Figure 4. Two-way 213 
analysis of variance revealed a significant effect of PZQ dietary inclusion level on ingestion 214 
(P = 0.002), but no effect of PZQ type (R-(−)-PZQ or Rac-PZQ) (P = 0.10) and no interaction 215 
between these factors (P = 0.25). Post hoc tests revealed that ingestion of diets medicated 216 
with 2.5 g kg-1 (65 ± 3%) and 5 g kg-1 (57 ± 3%) were significantly higher than those 217 
medicated with 10 g kg-1 (39 ± 3%). Ingestion of diets containing 2.5 and 5.0 g kg-1 of R-(−)-218 
PZQ were significantly higher than those containing 10.0 g kg-1 of Rac-PZQ. 219 
Discussion 220 
Our hypothesis that yellowtail kingfish would find R-(−)-PZQ more palatable than Rac-PZQ, 221 
which in turn would be more palatable than S-(+)-PZQ was rejected. Following the results of 222 
Trial 1 we hypothesised that the 2.2% of S-(+)-PZQ remaining within the enantioseparated R-223 
(−)-PZQ may be been the cause of the poor palatability, however the results from Trial 2 224 
demonstrated that this was not the case. Our findings are in contrast to studies in humans and 225 
cats and suggest that yellowtail kingfish may be more sensitive to the bitterness of PZQ. 226 
Oppel (2008) found that cats had better acceptance of an aqueous paste containing R-(−)-PZQ 227 
than the same paste containing S-(+)-PZQ, although acceptance of the former paste was not 228 
100%. Meyer et al. (2009) reported that humans found R-(−)-PZQ to be significantly less 229 
bitter than Rac-PZQ, however the authors also noted a great deal of variation between 230 
members of the taste panel, with 2 out of 15 finding R-(−)-PZQ to be more bitter than Rac-231 
PZQ. While these findings demonstrate that mammals find R-(−)-PZQ more appealing than 232 
Rac-PZQ and S-(+)-PZQ, they also highlight that it is not completely devoid of bitterness. 233 
Taste specificities vary greatly between fish species, but in general fish are considered to be 234 
more sensitive to taste than mammals (Kasumyan & Doving 2003). Channel catfish, Ictalurus 235 
 
 
punctatus (Rafinesque), for example, have nearly 100 times more taste buds than that of an 236 
adult human (Finger, Drake, Kotrschal, Womble & Dockstader 1991). Fish have also been 237 
demonstrated to be highly sensitive to bitterness, with bitter compounds such as quinine, 238 
papaverine, sodium ricinolete, caffeine and theophylline all eliciting inhibitory feeding 239 
responses across a range of fish species (Kasumyan & Doving 2003).  240 
 241 
In a previous study, we put forward the hypothesis that fish may become less sensitive to 242 
bitterness as they grow (Partridge et al. 2014), on the basis of reports of a decline in the 243 
number of taste buds in other fish species and animals as they age (Harvey & Batty 1998;  244 
Yamaguchi, Harada, Kanemaru & Kasahara 2001;  Shin, Cong, Cai, Kim, Maudsley, Egan & 245 
Martin 2012). The current trials do not support this; 1.2 kg yellowtail kingfish consumed 246 
substantially less medicated feed than small fish at a PZQ inclusion level of 10 g kg-1. 247 
This suggests that the larger yellowtail kingfish are more sensitive to the taste of PZQ than 248 
the smaller fish. Although there are no data on the ontogenetic change in taste bud density in 249 
Seriola spp., these results may indicate that density may increase to the sub-adult stage in 250 
yellowtail kingfish before declining. In Atlantic cod Gadus morhua (Linnaeus), which grow 251 
to ca.70 cm in length, taste bud density increases with fish size up to ca.10 cm before 252 
beginning to decline (Harvey & Batty 1998). Kohbara et al. (2000) found 3 kg wild Japanese 253 
yellowtail Seriola quinqueradiata (Temminck & Schlegel) to be less sensitive to five out of 254 
six chemicals tested than fish of ca. 40 grams, suggesting a decrease in taste sensitivity may 255 
occur at a large size in fish from this genus. Clearly further studies are needed on the taste 256 




During Trials 1, 2 and 3, we saw evidence that the S-(+)-PZQ enantiomer, which is reported 259 
to be more bitter in mammals, was ingested to a higher degree than both R-(−)-PZQ and Rac-260 
PZQ. While this difference was non-significant and limited to the first day of feeding in small 261 
fish, it was significant in the large fish. As previously reported, the S-(+)-PZQ was largely 262 
devoid of smell, whilst the characteristic smell of Rac-PZQ was concentrated and more acrid 263 
in the R-(−)-PZQ enantiomer. These factors suggest that smell may be an equal if not greater 264 
factor to the palatability of PZQ in yellowtail kingfish as taste. This is supported by other 265 
studies demonstrating that fish have a greater acuity for smell than taste. Channel catfish, for 266 
example, have the most taste buds of any fish species, yet are still 25 to 50 times more 267 
sensitive to the smell of the bitter compound quinine hydrochloride than its taste (Bardach & 268 
Atema 1971). In many fish species it has been demonstrated that the number and surface area 269 
of olfactory lamellae increases with age, suggesting an increase in sensitivity to smell (Hara 270 
1994). Our data showing a reduced acceptance of the stronger smelling R-(−)-PZQ in larger 271 
fish compared with the smaller fish supports yellowtail kingfish conforming to this 272 
generalised model. Whilst there appear to be no data on the ontogenetic changes in the 273 
number or surface areas of the olfactory lamellae in Seriola sp., preliminary analysis 274 
conducted on the 1.2 kg fish used in this study revealed 26 lamellae on each olfactory bulb. 275 
In freshwater fish, the number of olfactory lamellae ranges from two in the three-spined 276 
stickleback Gasterosteus aculeatus (Linnaeus) to more than 60 in the European eel Anguillia 277 
anguilla (Linnaeus), which is renowned for its highly sensitive sense of smell (Hara 1993).  278 
On the basis of this simple comparison we suggest that yellowtail kingfish may have an 279 
intermediate sensitivity to smell.  280 
 281 
Withholding food from fish for a few days prior to introducing diets medicated with PZQ has 282 
been suggested anecdotally as a method of encouraging fish to accept the diets. However, in 283 
 
 
most cases our data do not show any improvement in ingestion over the few days of these 284 
trials, suggesting that hunger is not a sufficient driving force to encourage the fish to consume 285 
the unpalatable diets, at least over these relatively short time periods. Indeed, the small fish in 286 
Trial 2 ate significantly less of the fifth day of the trial that in the previous four days. The 287 
only fish to show an improvement in intake over time were the large fish offered the diet 288 
containing the S-(+)-PZQ enantiomer.  289 
 290 
Despite the lack of evidence from this study that R-(−)-PZQ is more palatable than S-(+)-or 291 
Rac-PZQ, the incorporation of R-(−)-PZQ into diets may still be advantageous over the 292 
current practice of using Rac-PZQ. While the effectiveness of different PZQ enantiomers 293 
against monogenean parasites has yet to be determined, the S-(+)-PZQ enantiomer has 294 
virtually no antiparasitic effect against the trematode Schistosoma or cestodes (Andrews et al. 295 
1983;  Staudt et al. 1992). Our data demonstrate that dietary inclusion level is a more 296 
important factor in diet palatability than PZQ enantiomeric composition. Results from Trial 4, 297 
for example, demonstrated that the palatability of a diet containing 5 g kg-1 of R-(−)-PZQ was 298 
significantly greater than that containing 10 g kg-1 of Rac-PZQ, yet both diets would be 299 
equally efficacious if R-(−)-PZQ proves to be the only enantiomer effective against 300 
monogeneans. To the best of our knowledge, R-(−)-PZQ is not yet readily available on a 301 
large scale and therefore its commercial cost is unknown. It is safe to assume, however that 302 
the cost will be at least double that of racemic PZQ as the resolution process begins with 303 
racemic PZQ and retains at best only half of the starting material, with the S-(+)-PZQ being 304 
discarded.  305 
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Table Captions:  392 
Table 1: Treatments investigated in each trial. 1 = 97.8% R-(−)-PZQ, 2 = 99.6% R-(−)-393 
PZQ, * = 88.2% S-(+)-PZQ. 394 
 395 
Figure Captions:  396 
 397 
Figure 1: Ingestion of diets medicated with different enantiomers of PZQ by small 398 
yellowtail kingfish over time in Trial 1.  399 
 400 
Figure 2:  Ingestion of diets medicated with different enantiomers of PZQ by small 401 
yellowtail kingfish over time in Trial 2. 402 
 403 
Figure 3:  Ingestion of diets medicated with different enantiomers of PZQ by large 404 
yellowtail kingfish over time. 405 
 406 
Figure 4:  Effect of dietary inclusion level on ingestion of diets medicated with different 407 
enantiomers of PZQ by small yellowtail kingfish. Columns sharing the same 408 
letter are not significantly different (P>0.05). 409 
  410 
 
 
Table 1 411 
 412 
Trial Treatment Active PZQ Inclusion  Fish size Temperature 
  (g PZQ kg diet-1)  (g ± S.D) (°C) 
     
     
1 R-(−)-PZQ1 10 160 ± 45 23.1 
(n = 3) S-(+)-PZQ* 10   
 Rac-PZQ 10   
 Control 0   
     
2 R-(−)-PZQ1 10 85 ± 1 20.5 
 R-(−)-PZQ2 10   
(n = 3) S-(+)-PZQ* 10   
 Rac-PZQ 10   
 Control 0   
     
3 R-(−)-PZQ2 10 1175 ± 221 21.5 
(n = 2) S-(+)-PZQ* 10   
 Rac-PZQ 10   
     
4 R-(−)-PZQ2 2.5 170 ± 22 18.5 
(n = 2) R-(−)-PZQ2 5   
 R-(−)-PZQ2 10   
 Rac-PZQ 2.5   
 Rac-PZQ 5   
 Rac-PZQ 10   
 Control 0   
     
 413 
 414 
